Location: Palo Alto, CA
CIK: 0001744967 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $174M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Intercept Pharmaceuticals Inc | 403,688 | $25.42M | 14.6% | $88.27 | — | COM | 45845P108 |
| — | Principia Biopharma Inc | 401,046 | $23.81M | 13.7% | $34.91 | — | COM | 74257L108 |
| — | Springworks Therapeutics Inc | 625,281 | $16.88M | 9.7% | $21.68 | — | COM | 85205L107 |
| — | Odonate Therapeutics Inc | 522,637 | $14.43M | 8.3% | $14.81 | — | COM | 676079106 |
| — | Allakos Inc | 270,965 | $12.05M | 6.9% | $51.45 | — | COM | 01671P100 |
| — | Sutro BioPharma Inc | 1,125,579 | $11.48M | 6.6% | $9.02 | — | COM | 869367102 |
| — | Atreca Inc | 596,838 | $9.878M | 5.7% | $18.84 | — | COM | 04965G109 |
| — | Syros Pharmaceuticals Inc | 1,726,603 | $9.599M | 5.5% | $6.82 | — | COM | 87184Q107 |
| LQDA | Liquidia Technologies Inc | 1,013,773 | $4.775M | 2.7% | $6.51 | -23.8% | COM | 53635D202 |
| — | Hookipa Pharma Inc | 530,245 | $4.375M | 2.5% | $6.73 | — | COM | 43906K100 |
| RYTM | Rhythm Pharmaceuticals Inc | 276,289 | $4.205M | 2.4% | $17.90 | 0.0% | COM | 76243J105 |
| — | Millendo Therapeutics Inc | 751,301 | $3.967M | 2.3% | $6.81 | — | COM | 60040X103 |
| — | Bellus Health Inc | 394,431 | $3.917M | 2.3% | $7.55 | — | COM | 07987C204 |
| — | Pieris Pharmaceuticals Inc | 1,620,249 | $3.694M | 2.1% | $2.86 | — | COM | 720795103 |
| — | Aimmune Therapeutics, Inc. | 232,571 | $3.354M | 1.9% | $14.42 | — | COM | 00900T107 |
| — | Aravive Inc | 576,066 | $3.318M | 1.9% | $5.87 | — | COM | 03890D108 |
| — | Iveric Bio, Inc. | 862,552 | $2.967M | 1.7% | $7.61 | — | COM | 46583P102 |
| ACRS | Aclaris Therapeutics, Inc. | 2,608,117 | $2.712M | 1.6% | $1.36 | 0.0% | COM | 00461U105 |
| — | Sunesis Pharmaceuticals Inc | 5,938,215 | $2.464M | 1.4% | $0.75 | — | COM | 867328700 |
| RCKT | Rocket Pharmaceuticals Inc | 128,197 | $1.788M | 1.0% | $19.80 | 0.0% | COM | 77313F106 |
| UROV | Urovant Sciences Ltd | 157,480 | $1.452M | 0.8% | $6.59 | — | COM | G9381B108 |
| KALV | KalVista Pharmaceuticals Inc | 168,174 | $1.287M | 0.7% | $18.15 | -25.7% | COM | 483497103 |
| — | Catabasis Pharmaceuticals Inc | 300,000 | $1.245M | 0.7% | $4.37 | — | COM | 14875P206 |
| — | Bluebird Bio Inc | 24,790 | $1.139M | 0.7% | $45.95 | — | COM | 09609G100 |
| — | Portola Pharmaceuticals Inc | 159,772 | $1.139M | 0.7% | $7.13 | — | COM | 737010108 |
| — | Akero Therapeutics, Inc. | 50,000 | $1.06M | 0.6% | $21.20 | — | COM | 00973Y108 |
| — | Amarin Corp PLC | 195,195 | $781K | 0.4% | $4.00 | — | SPONS ADR NEW | 023111206 |
| — | Kala Pharmaceuticals Inc | 64,102 | $563K | 0.3% | $8.78 | — | COM | 483119103 |